Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vaxart ( (VXRT) ) just unveiled an announcement.
On April 20, 2026, Vaxart, Inc. amended its lease agreement with its Utah Avenue landlord in South San Francisco to add two suites totaling approximately 3,531 rentable square feet, with the new space becoming effective on May 14, 2026, for a 36‑month term. This expansion follows a December 2025 termination agreement under which Vaxart and its Harbor Way landlord agreed to end the company’s roughly 24,606‑square‑foot headquarters lease at 170 Harbor Way effective May 15, 2026, signaling a relocation and consolidation of its footprint within South San Francisco.
The most recent analyst rating on (VXRT) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Vaxart stock, see the VXRT Stock Forecast page.
Spark’s Take on VXRT Stock
According to Spark, TipRanks’ AI Analyst, VXRT is a Neutral.
The score is driven mainly by the improved TTM financial profile (rapid revenue growth and a return to profitability/positive cash flow), tempered by concerns about sustainability given historically volatile results and a smaller equity cushion. Technicals are supportive with the stock above key moving averages, while valuation looks inexpensive on P/E but lacks dividend support and relies on potentially non-recurring earnings. Earnings call factors are constructive due to partnership validation and extended runway, but remain risk-weighted due to BARDA-related delays and partner-dependency.
To see Spark’s full report on VXRT stock, click here.
More about Vaxart
Vaxart, Inc. is a biotechnology company that develops pharmaceutical products and operates in the life sciences industry. The company maintains facilities in South San Francisco, California, where it leases office and laboratory space to support its corporate and research operations.
Average Trading Volume: 513,121
Technical Sentiment Signal: Hold
Current Market Cap: $175.5M
For detailed information about VXRT stock, go to TipRanks’ Stock Analysis page.